NTRA vs PTCT Stock Comparison
PTCT currently leads NTRA in this stock comparison, with AIQ scores of 54 vs 48. The clearest difference is quality, while NTRA has the stronger momentum profile.
What is the main difference between NTRA and PTCT?
PTCT leads the current stock comparison as PTC Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Natera, Inc. vs PTC Therapeutics, Inc.
PTCT leads
PTCT leads by 6 AIQ points, primarily on Quality and Value, having only recently taken the lead back from NTRA.
Fragile: 4 of 6 evidence groups support PTCT, the lead recently changed hands, and its current signal state is conflicted.
Natera, Inc.
PTC Therapeutics, Inc.
The Algovestiq AIQ Score currently favors PTCT over NTRA, 54 versus 48 as of Oct 21, 2026. PTCT's advantage is driven primarily by stronger quality and value, while NTRA holds the stronger momentum profile. PTCT also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor PTCT today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. PTCT lead: Reversed — NTRA led by 7 AIQ points 30 sessions ago; PTCT now leads by 6.
Compare Natera, Inc. and PTC Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare NTRA and PTCT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality57 vs 82PTCT +25
- Momentum47 vs 37NTRA +10
- Value34 vs 38PTCT +4
- Risk Resilience57 vs 55Even
4 of 6 evidence groups favor PTCT. PTCT’s edge is concentrated in quality and value; NTRA keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +5
No signal started or stopped since the prior session; its 5 active signals are unchanged.
Largest factor move: Momentum +5
New signals
- MACD Bullish Crossover — bullish, momentum, short horizon
PTCT's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — NTRA and PTCT both carry a full feed there.
The central trade-off
PTCT (PTC Therapeutics, Inc.): the stronger current systematic profile, led by quality and value.
NTRA (Natera, Inc.): the counter-case, on momentum, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PTCTPTCT on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
PTCTPTCT on combined revenue and EPS growth.
Value
PTCTPTCT on the peer-relative Value factor, by 4 points.
Momentum
NTRANTRA on the Momentum factor, by 10 points.
Lower downside
NTRANTRA carries the lower 1-month annualized volatility.
Analyst upside
PTCTPTCT on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | NTRA | PTCT | Note |
|---|---|---|---|
| Implied upside to target | -19.6% | +64.4% | PTCT has more room |
| Target dispersion | +76.7% | +60.2% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 15 | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor PTCT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PTCT | 48 vs 54 |
| Fundamentals | PTCT | revenue growth 8.1% vs 32.3%; EPS growth 21.7% vs 34.7%; TTM ROE -11.7% vs 21.7%; gross margin 65.3% vs 82.1%; operating margin -10.7% vs 11.5% |
| Valuation | PTCT | Value 34 vs 38 |
| Technicals | NTRA | Price vs 50-day 14.4% vs -6.6%; vs 200-day 56.6% vs -11.7% |
| Risk Resilience | Even | Risk Resilience 57 vs 55 |
| Analyst expectations | PTCT | Target upside -19.6% vs 64.4% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of NTRA and PTCT and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 6 points.
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PTCT.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20PTCT lead: Reversed — NTRA led by 7 AIQ points 30 sessions ago; PTCT now leads by 6.
- Today
- PTCT +6
- 48 vs 54
- 7 sessions ago
- PTCT +7
- 47 vs 54
- 30 sessions ago
- NTRA +7
- 60 vs 53
- 90 sessions ago
- NTRA +4
- 58 vs 54
The lead changed hands 4 times in this window, most recently on Oct 8 when PTCT moved ahead of NTRA.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 1 bearish / 1 neutral, conflicted
Only NTRA
- Golden Cross Active — bullish, trend, long horizon (39.40%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
1 bullish / 2 bearish / 2 neutral, conflicted
Only PTCT
- Bollinger Band Squeeze — neutral, volatility, short horizon
- Death Cross Active — bearish, trend, long horizon (6.34%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.
PTCT leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +1.84%, AIQ +2 points).
Price is down while the AIQ Score moved up 2 points over the same session — price and model disagree (price -0.48%, AIQ +2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1NTRA closes the Quality gap — currently 25 points behind, the largest single contributor to PTCT's edge.
- 2NTRA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
- 3PTCT's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
PTCT leads on balance| Metric | NTRA | PTCT |
|---|---|---|
| Revenue growth (YoY) | 8.1% | 32.3% |
| EPS growth (YoY) | 21.7% | 34.7% |
| Gross margin | 65.3% | 82.1% |
| Operating margin | -10.7% | 11.5% |
| Return on equity (TTM) | -11.7% | 21.7% |
| Debt to equity | 0.13 | -4.21 |
Performance
NTRA leads 5 of 6 windows| Metric | NTRA | PTCT |
|---|---|---|
| 1 week (5 sessions) | 2.6% | 5% |
| 1 month (20 sessions) | 3.8% | -4.6% |
| 3 months (63 sessions) | 53.6% | -19.7% |
| 6 months (126 sessions) | 97.6% | -10.9% |
| Year to date | 77.2% | -17.2% |
| 1 year (252 sessions) | 124.8% | -5.8% |
Technicals
NTRA has the stronger structure| Metric | NTRA | PTCT |
|---|---|---|
| RSI (14) | 46.5 | 44.4 |
| ADX (14) | 41.5 | 18.3 |
| Price vs 50-day | 14.4% | -6.6% |
| Price vs 200-day | 56.6% | -11.7% |
| Volatility (1M, annualized) | 36.7% | 42.9% |
Risk
Split| Metric | NTRA | PTCT |
|---|---|---|
| Beta | 1.24 | 0.74 |
| Sharpe ratio | 1.82 | -0.01 |
| Sortino ratio | 2.95 | -0.01 |
| Max drawdown | -28.2% | -33.9% |
| Current drawdown | -4.6% | -29.7% |
| Annualized volatility | 48.5% | 40.8% |
| Value at risk (95%) | -3.8% | -4.1% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, NTRA or PTCT?
On the Algovestiq AIQ Score, PTCT is the stronger of the two as of Oct 21, 2026, scoring 54 against NTRA's 48. The edge comes from quality and value. NTRA is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is NTRA or PTCT the better buy right now?
PTCT carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.
Why does the AIQ Score favor PTCT over NTRA?
The composite weights Quality, Value, Momentum and Risk Resilience. PTCT leads Quality by 25 points; NTRA leads Momentum by 10 points; PTCT leads Value by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, NTRA or PTCT?
Analyst price targets imply -19.6% upside for NTRA and +64.4% for PTCT, so the Street currently favors PTCT. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, NTRA or PTCT?
PTCT is the better-valued of the two on the peer-relative Value factor. PTCT on the peer-relative Value factor, by 4 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, NTRA or PTCT?
PTCT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, NTRA or PTCT?
NTRA on the Momentum factor, by 10 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, NTRA or PTCT?
NTRA is the more resilient of the two, so the other name carries the higher downside risk. NTRA carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is NTRA more profitable than PTCT?
PTCT leads on the comparable margin measures — gross margin 65.3% vs 82.1%; operating margin -10.7% vs 11.5%; ttm roe -11.7% vs 21.7%.
Is PTCT's lead over NTRA getting stronger or weaker?
PTCT lead: Reversed — NTRA led by 7 AIQ points 30 sessions ago; PTCT now leads by 6. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands 4 times in that window, most recently on 2026-10-08, when PTCT moved ahead of NTRA.
What would change the NTRA vs PTCT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: NTRA closes the Quality gap — currently 25 points behind, the largest single contributor to PTCT's edge; NTRA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; PTCT's conflicting signal state resolves bearish — it currently carries 1 bullish and 2 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about NTRA and PTCT?
NTRA: 3 bullish / 1 bearish / 1 neutral, conflicted. PTCT: 1 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on NTRA is Golden Cross Active (bullish, long horizon). On PTCT it is Death Cross Active (bearish, long horizon).
Compare NTRA and PTCT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.